This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shionogi Company Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Atsushi Fujihira: Innovator in Pharmaceutical Composition
Introduction
Atsushi Fujihira is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for medical use. His work is characterized by a focus on innovative solutions that enhance the efficacy and stability of pharmaceutical products.
Latest Patents
Atsushi Fujihira holds 1 patent for his invention titled "Preparation containing cephalosporin having a catechol moiety." This patent relates to a stable pharmaceutical composition that includes a compound represented by a specific formula, its pharmaceutically acceptable salt, or a solvate thereof. The composition is designed to be prepared using a combination of alkali metal chlorides, alkaline earth metal chlorides, transition metal chlorides, magnesium chloride, and sugar or sugar alcohol.
Career Highlights
Fujihira is associated with Shionogi Company Limited, a prominent pharmaceutical company known for its commitment to research and development. His work at Shionogi has allowed him to focus on creating innovative pharmaceutical solutions that address various medical needs.
Collaborations
Throughout his career, Atsushi Fujihira has collaborated with esteemed colleagues, including Hidenori Kawasaki and Natsuko Kojima. These collaborations have contributed to the advancement of pharmaceutical research and the development of new therapeutic compositions.
Conclusion
Atsushi Fujihira's contributions to the pharmaceutical industry exemplify the importance of innovation in medical science. His patent for a stable pharmaceutical composition showcases his dedication to improving healthcare solutions. His work continues to influence the field and inspire future advancements in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
